HYPERPHAGIA IN PRADER-WILLI SYNDROME
Clinical trials for HYPERPHAGIA IN PRADER-WILLI SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HYPERPHAGIA IN PRADER-WILLI SYNDROME trials appear
Sign up with your email to follow new studies for HYPERPHAGIA IN PRADER-WILLI SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New nasal spray aims to curb relentless hunger in rare genetic disorder
Disease control ENROLLING_BY_INVITATIONThis study tests the long-term safety of a nasal spray called carbetocin for people with Prader-Willi syndrome who experience severe, constant hunger (hyperphagia). About 160 participants who completed a previous study will receive the spray three times daily. The goal is to see …
Matched conditions: HYPERPHAGIA IN PRADER-WILLI SYNDROME
Phase: PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New nasal spray aims to tame relentless hunger in rare genetic disorder
Symptom relief OngoingThis Phase 3 trial tests a nasal spray called carbetocin to reduce the intense, constant hunger (hyperphagia) in people with Prader-Willi syndrome. The study involves 170 participants aged 5 to 30 and lasts 12 weeks. Caregivers will rate changes in hunger-related behaviors using …
Matched conditions: HYPERPHAGIA IN PRADER-WILLI SYNDROME
Phase: PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 16:16 UTC